Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 140, Issue 2, 2008, Pages 263-268

  Lenhard, S M ^a   Burges, A ^a   Johnson, T R C ^a   Kirschenhofer, A ^a   Bruns, C ^b   Linke, R ^a   Friese, K ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytoreductive surgery; Ovarian cancer; Positron emission tomography computed tomography; Relapse; Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; METASTASIS; OVARY CANCER; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 52949086797     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.05.006     Document Type: Article

References (21)

1. Cannistra S.A. Cancer of the ovary. N Engl J Med 329 21 (1993) 1550-1559
2. Berek J.S., Trope C., and Vergote I. Surgery during chemotherapy and at relapse of ovarian cancer. Ann Oncol 10 Suppl. 1 (1999) 3-7
3. Omura G.A., Brady M.F., Homesley H.D., et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9 7 (1991) 1138-1150
4. Thigpen J.T., Vance R.B., and Khansur T. Second-line chemotherapy for recurrent carcinoma of the ovary. Cancer 71 4 Suppl. (1993) 1559-1564
5. Markman M. The use of PET scanning in ovarian cancer. Gynecol Oncol 85 2 (2002) 391 [author reply 391-2]
6. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 5 (2002) 1248-1259
7. Hoskins W.J., Bundy B.N., Thigpen J.T., and Omura G.A. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47 2 (1992) 159-166
8. van der Burg M.E., van Lent M., Buyse M., et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332 10 (1995) 629-634
9. Rose P.G., Nerenstone S., Brady M.F., et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 351 24 (2004) 2489-2497
10. Harter P., Bois A., Hahmann M., et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 13 12 (2006) 1702-1710
11. Rustin G.J., Nelstrop A.E., Tuxen M.K., and Lambert H.E. Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study. Ann Oncol 7 4 (1996) 361-364
12. Charron M., Beyer T., Bohnen N.N., et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 25 11 (2000) 905-910
13. Kluetz P.G., Meltzer C.C., Villemagne V.L., et al. Combined PET/CT imaging in oncology. impact on patient management. Clin Positron Imaging 3 6 (2000) 223-230
14. Martinelli M., Townsend D., Meltzer C., and Villemagne V.V. 7. Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET Facility. Clin Positron Imaging 3 4 (2000) 161
15. Makhija S., Howden N., Edwards R., Kelley J., Townsend D.W., and Meltzer C.C. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85 1 (2002) 53-58
16. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 6 (1982) 649-655
17. Zang R.Y., Li Z.T., Tang J., et al. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?. Cancer 100 6 (2004) 1152-1161
18. Eisenkop S.M., Friedman R.L., and Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 88 1 (2000) 144-153
19. Bristow R.E., del Carmen M.G., Pannu H.K., et al. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90 3 (2003) 519-528
20. Hauth E.A., Antoch G., Stattaus J., et al. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer. Eur J Radiol 56 2 (2005) 263-268
21. Salani R., Santillan A., Zahurak M.L., et al. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer 109 4 (2007) 685-691